Literature DB >> 21422409

Failure to validate toxicity and outcome biomarkers from the FFCD 2000-05 trial in the MRC CR08 FOCUS trial.

Susan D Richman, Jennifer H Barrett, Matthew T Seymour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21422409      PMCID： PMC3082980          DOI： 10.1200/JCO.2010.33.9556

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05.

Authors:  Valérie Boige; Jean Mendiboure; Jean-Pierre Pignon; Marie-Anne Loriot; Marine Castaing; Michel Barrois; David Malka; David-Alexandre Trégouët; Olivier Bouché; Delphine Le Corre; Isabelle Miran; Claire Mulot; Michel Ducreux; Philippe Beaune; Pierre Laurent-Puig
Journal:  J Clin Oncol       Date:  2010-04-12       Impact factor: 44.544

2.  Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.

Authors:  Matthew T Seymour; Timothy S Maughan; Jonathan A Ledermann; Clare Topham; Roger James; Stephen J Gwyther; David B Smith; Stephen Shepherd; Anthony Maraveyas; David R Ferry; Angela M Meade; Lindsay Thompson; Gareth O Griffiths; Mahesh Kb Parmar; Richard J Stephens
Journal:  Lancet       Date:  2007-07-14       Impact factor: 79.321
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.